Your browser doesn't support javascript.
loading
INSPIRE: A European training network to foster research and training in cardiovascular safety pharmacology.
Guns, Pieter-Jan D; Guth, Brian D; Braam, Stefan; Kosmidis, Georgios; Matsa, Elena; Delaunois, Annie; Gryshkova, Vitalina; Bernasconi, Sylvain; Knot, Harm J; Shemesh, Yair; Chen, Alon; Markert, Michael; Fernández, Miguel A; Lombardi, Damiano; Grandmont, Céline; Cillero-Pastor, Berta; Heeren, Ron M A; Martinet, Wim; Woolard, Jeanette; Skinner, Matt; Segers, Vincent F M; Franssen, Constantijn; Van Craenenbroeck, Emeline M; Volders, Paul G A; Pauwelyn, Thomas; Braeken, Dries; Yanez, Paz; Correll, Krystle; Yang, Xi; Prior, Helen; Kismihók, Gábor; De Meyer, Guido R Y; Valentin, Jean-Pierre.
Afiliação
  • Guns PD; Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium. Electronic address: pieter-jan.guns@uantwerpen.be.
  • Guth BD; Boehringer Ingelheim Pharma GmbH & Co KG, Drug Discovery Sciences, Biberach an der Riss, Germany.
  • Braam S; Ncardia B.V, Leiden, the Netherlands.
  • Kosmidis G; Ncardia B.V, Leiden, the Netherlands.
  • Matsa E; Ncardia B.V, Leiden, the Netherlands.
  • Delaunois A; UCB Biopharma SRL, Early Solutions, Development Science, Non-Clinical Safety Evaluation, Braine-l'Alleud, Belgium.
  • Gryshkova V; UCB Biopharma SRL, Early Solutions, Development Science, Non-Clinical Safety Evaluation, Braine-l'Alleud, Belgium.
  • Bernasconi S; NOTOCORD, an Instem company, Le Pecq, France.
  • Knot HJ; TSE Systems GmbH, Bad Homburg, Germany.
  • Shemesh Y; Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.
  • Chen A; Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel.
  • Markert M; Boehringer Ingelheim Pharma GmbH & Co KG, Drug Discovery Sciences, Biberach an der Riss, Germany.
  • Fernández MA; Inria, Sorbonne Université & CNRS, Paris, France.
  • Lombardi D; Inria, Sorbonne Université & CNRS, Paris, France.
  • Grandmont C; Inria, Sorbonne Université & CNRS, Paris, France.
  • Cillero-Pastor B; The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, the Netherlands.
  • Heeren RMA; The Maastricht MultiModal Molecular Imaging Institute (M4I), Division of Imaging Mass Spectrometry, Maastricht University, Maastricht, the Netherlands.
  • Martinet W; Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium.
  • Woolard J; Division of Physiology, Pharmacology and Neuroscience, Centre of Membrane Proteins and Receptors (COMPARE), School of Life Sciences, University of Nottingham, United Kingdom.
  • Skinner M; Vivonics Preclinical Ltd, BioCity, Nottingham, United Kingdom.
  • Segers VFM; Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium; Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium.
  • Franssen C; Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium; Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.
  • Van Craenenbroeck EM; Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium; Cardiovascular Diseases, GENCOR, University of Antwerp, Antwerp, Belgium.
  • Volders PGA; Department of Cardiology, CARIM, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Pauwelyn T; Life Science Technologies, imec, Leuven, Belgium.
  • Braeken D; Life Science Technologies, imec, Leuven, Belgium.
  • Yanez P; Department of Research Affairs & Innovation, University of Antwerp, Antwerp, Belgium.
  • Correll K; Safety Pharmacology Society, Reston, Virginia, United States.
  • Yang X; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, United States.
  • Prior H; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.
  • Kismihók G; Leibniz Information Centre for Science and Technology, Hannover, Germany; Marie Curie Alumni Association, Brussels, Belgium.
  • De Meyer GRY; Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium.
  • Valentin JP; UCB Biopharma SRL, Early Solutions, Development Science, Non-Clinical Safety Evaluation, Braine-l'Alleud, Belgium.
J Pharmacol Toxicol Methods ; 105: 106889, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32565326
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacologia / Sistema Cardiovascular / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Desenvolvimento de Medicamentos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacologia / Sistema Cardiovascular / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Desenvolvimento de Medicamentos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article